Most Recent Flipbooks
WCG ThreeWire– Phase II Dermatology Study
WCG ThreeWire– Oncology Study
WCG ThreeWire– Overcoming Enrollment Challenges– Ulcerative Colitis
WCG ThreeWire– Difficult-to-Recruit Populations– Vaccine Study
WCG ThreeWire– Psoriatic Arthritis
How Celgene Transformed Its Safety-Reporting Process, Saving $5.7 million In One Year
Accurate Pain Reporting for Painful Diabetic Neuropathy
WCG Analgesic Solutions found that patients could better report their pain intensity and discriminate between active drug and placebo using APR (accurate pain reporting) training.
By the Numbers: Six Challenges to Enrollment, One Customized Solution
How WCG ThreeWire Rescued an Under-performing Phase II Constipation Drug Study
How a Top Pharma Company Successfully Enrolled for a MDD Study
ThreeWire was able to quickly review charts at the 48 sites, leading to 121 consents and 69 enrolled subjects. These efforts contributed 34.5% of all enrollments.
How a Sponsor Secured 200 High-Performing PI's in a New TA in Just 5 Days
Global Osteoarthritis Program facing FDA Safety Concerns
Finding an Agile PV Partner for Early-Stage Clinical Development
Rescuing Two Global Immuno-Oncology Trials with Contracts & Budgets
Partnering for the Future: Rescuing Contracts & Budgets for 10 Global Phase II & III Studies
OhioHealth Case Study
Dissatisfied with its electronic IRB research management solution, OhioHealth Research & Innovation Institute searched for a solution to improve compliance, efficiency, customer service, and cost.
Recruitment Case Study for Osteoarthritis Pain Program
WCG ThreeWire Recruitment Success: 70% of Total Randomization
Study Marketing for Medical Device Sleep Study - US
Enrollment Services Phase III Oncology Drug Study - US & Europe